References
- Mygind N, Vesterhauge S. Aerosol distribution in the nose. Rhinology 1978; 16: 79–88
- Hardy J G, Lee S W, Wilson C G. Intranasal drug delivery by spray and drops. J Pharm Pharmacol 1985; 37: 294–7
- Mygind N. Upper airway: Structure, function and therapy. Aerosols in medicine. Principles, diagnoses and therapy, F Mordn, M T Newhouse, M B Dolovich. Elsevier, Amsterdam 1985; 1–20
- Charlton R, Mackay I, Wilson R, Cole P. Double-blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. Br Med J 1985; 291: 788
- Harris A S, Nilsson I M, Wagner Z G, Alkner U. Intranasal administration of peptides: Nasal deposition, biological response, and absorption of desmopressin. J Pharm Sci 1986; 75: 1085–8
- Aoki F Y, Crawley J CW. Distribution and removal of human serum albumin–technetium 99m instilled intranasally. Br J Clin Pharmacol 1976; 3: 859–78
- Proctor D F. The mucociliary system. The nose: Upper airway physiology and the atmospheric environment, D F Proctor, I Andersson. Elsevier, Amsterdam 1982; 245
- Bond S W, Hardy J G, Wilson C G. Deposition and clearance of nasal sprays. Proceedings of second European Congress of Biopharmaceutics and Pharmacokinetics., J M Aiache, J Hirtz. Libraries Lavoisier, Paris 1984; 93–8